Theravance Receives Complete Response Letter on the Telavancin NDA
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
SOUTH SAN FRANCISCO, CA/November 27, 200 ... more>>
Tags: complete response,
the treatment,
response letter,
nosocomial pneumonia,
conference call,
product candidates,
forward-looking statements,
astellas pharma,
fda guidelines,
elderly patients,
adverse reactions,
clinical studies,
new drug application,
theravance inc,
gram-positive bacteria
Views: 0
Language: English